Compare · ENOV vs ZBH
ENOV vs ZBH
Side-by-side comparison of Enovis Corporation (ENOV) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ENOV and ZBH operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ZBH is the larger of the two at $18.00B, about 16.1x ENOV ($1.12B).
- Over the past year, ENOV is down 39.5% and ZBH is down 7.6% - ZBH leads by 31.9 points.
- ZBH has been more active in the news (13 items in the past 4 weeks vs 3 for ENOV).
- ZBH has more recent analyst coverage (25 ratings vs 20 for ENOV).
- Company
- Enovis Corporation
- Zimmer Biomet Holdings Inc.
- Price
- $19.61+1.37%
- $94.99+0.62%
- Market cap
- $1.12B
- $18.00B
- 1M return
- +10.26%
- +0.77%
- 1Y return
- -39.49%
- -7.55%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 3
- 13
- Recent ratings
- 20
- 25
Enovis Corporation
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest ENOV
- Enovis to Host Third Quarter 2026 Results Conference Call on November 5th
- Director Ortiz Christine was granted 958 shares, increasing direct ownership by 4% to 26,815 units (SEC Form 4)
- Nyxoah Appoints Liam Kelly as Chief Executive Officer
- Enovis becomes first multi-registry industry sponsor of AAOS Registry Program
- Chief Administrative Officer Engert Oliver bought $50,008 worth of shares (2,660 units at $18.80), increasing direct ownership by 4% to 63,898 units (SEC Form 4)
- Chief Executive Officer Mcdonald Damien bought $249,620 worth of shares (13,035 units at $19.15), increasing direct ownership by 6% to 247,077 units (SEC Form 4)
- Chief Administrative Officer Engert Oliver bought $149,971 worth of shares (7,598 units at $19.74), increasing direct ownership by 14% to 61,238 units (SEC Form 4)
- eCential Robotics Announces Binding Offer from Enovis
- Enovis Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics
Latest ZBH
- ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT
- Barclays initiated coverage on Zimmer Biomet with a new price target
- Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results
- SEC Form 4 filed by Zimmer Biomet Holdings Inc.
- SEC Form 3 filed by Zimmer Biomet Holdings Inc.
- SEC Form 3 filed by Zimmer Biomet Holdings Inc.
- SEC Form 4 filed by Director Farrell Michael J.
- SEC Form 4 filed by Director Hagemann Robert
- SEC Form 4 filed by Director Higgins Arthur J
- SEC Form 4 filed by Director Shapiro Louis